Remove Biopharma Remove Doctors Remove Medical science Remove Patients
article thumbnail

Precision Medicine Requires Opportunities to Connect with Patients

PM360

When Marc’s doctors discovered he had a rare liver condition, it almost felt like a relief. With the development of new technology platforms at breakneck speed, companies are positioning themselves to one day deliver game-changing solutions to patients in their niche—solutions they may have been waiting for all their life.

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.

article thumbnail

Imagene Profiles Cancer Biomarkers in Real Time

Medgadget

Cancer therapies have proliferated over the past few decades, improving outcomes for many patients. Dean recounted how only two decades ago we only had access to one-size-fits-all treatments that were effective for some patients, but did nothing for others.